MedTrace Logo

Hip Replacement System (HRS-P) in Primary Total Hip Arthroplasty

NCT02836262 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-04-01

No results posted yet for this study

Summary

To evaluate effectiveness and safety of HHRS in subjects undergoing total hip arthroplasty (THA). Effectiveness will be evaluated using patient-reported, clinical, radiologic, and radiostereometric outcomes. Safety will be evaluated through the collection of device-related and unanticipated device-related adverse events.

Conditions

  • Osteoarthritis of Hip

Interventions

DEVICE

HIT Hip Replacement System

HIT Hip Replacement System

Sponsors & Collaborators

  • Hip Innovation Technology

    lead INDUSTRY

Principal Investigators

  • Thomas Turgeon, MD · Orthopaedic Innovation Centre

  • Branko Kopjar, MD, PhD · Nor Consult, LLC

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
65 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-25
Primary Completion
2025-08-25
Completion
2026-08-25

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02836262 on ClinicalTrials.gov